- 专利标题： Polymorphic forms of naltrexone
-
申请号： US15961201申请日： 2018-04-24
-
公开(公告)号： US10166228B2公开(公告)日： 2019-01-01
- 发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
- 申请人： Alkermes Pharma Ireland Limited
- 申请人地址： IE Dublin
- 专利权人： Alkermes Pharma Ireland Limited
- 当前专利权人： Alkermes Pharma Ireland Limited
- 当前专利权人地址： IE Dublin
- 代理机构： Elmore Patent Law Group, P.C.
- 代理商 Edgar Harlan; Carolyn Elmore
- 主分类号： A61K31/485
- IPC分类号： A61K31/485 ; C07D489/08 ; C07D489/06 ; C07C19/03
摘要：
This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
公开/授权文献
- US20180303825A1 POLYMORPHIC FORMS OF NALTREXONE 公开/授权日：2018-10-25
信息查询
IPC分类:
